Allelotype of endometrial carcinoma.
An allelotype analysis of endometrial carcinoma was undertaken to identify chromosomal loci that are relevant to this tumor type. A total of 70 highly polymorphic microsatellite markers, distributed among all nonacrocentric chromosome arms, were examined for evidence of loss of heterozygosity or allelic imbalance in DNA samples from matched normal and tumor tissues. An average of 21 informative tumor cases were obtained for each marker. Allelic deletions or imbalance were observed on 31 of 41 chromosome arms with no marker showing an allelic loss ratio of greater than 33%. Those chromosome arms most frequently involved were 3p, 8p, 9p, 14q, 16q and 18q. There was a strong correlation between loss of heterozygosity on chromosome 14q and death from disease. These data indicate that the molecular genetic character of endometrial carcinoma is complex and that a relatively large number of different chromosomal loci are likely to play a role in the etiology and progression of this tumor type.
Fujino
T
T
Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709.
Risinger
J I
JI
Collins
N K
NK
Liu
F S
FS
Nishii
H
H
Takahashi
H
H
Westphal
E M
EM
Barrett
J C
JC
Sasaki
H
H
Kohler
M F
MF
D002883:Chromosomes, Human, Pair 14; D002885:Chromosomes, Human, Pair 16; D002887:Chromosomes, Human, Pair 18; D002893:Chromosomes, Human, Pair 3; D002898:Chromosomes, Human, Pair 8; D002899:Chromosomes, Human, Pair 9; D016889:Endometrial Neoplasms / Q000235:genetics* / Q000473:pathology; D005260:Female; D017353:Gene Deletion; D005819:Genetic Markers; D005838:Genotype; D006801:Humans; D011379:Prognosis
D005819:Genetic Markers